Powell Lynne
Insider CIK 1631667 · PROG Director · BCRX Senior VP - CCO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BIOR BIORA THERAPEUTICS, INC. | A Award deriv | 2024-06-05 | 2024-06-06 | 12,500 | — | $0 | 12,500 | SEC↗ |
| BIOR BIORA THERAPEUTICS, INC. | A Award | 2024-06-05 | 2024-06-06 | 12,500 | — | $0 | 30,746 | SEC↗ |
| BIOR BIORA THERAPEUTICS, INC. | A Award deriv | 2023-06-14 | 2023-06-16 | 12,500 | — | $0 | 12,500 | SEC↗ |
| BIOR BIORA THERAPEUTICS, INC. | A Award | 2023-06-14 | 2023-06-16 | 12,500 | — | $0 | 18,246 | SEC↗ |
| BIOR BIORA THERAPEUTICS, INC. | D To issuer | 2023-01-03 | 2023-01-05 | 45 | — | $0 | 0 | SEC↗ |
| BIOR BIORA THERAPEUTICS, INC. | A Award deriv | 2022-06-15 | 2022-06-17 | 148,810 | — | $0 | 148,810 | SEC↗ |
| BIOR BIORA THERAPEUTICS, INC. | A Award | 2022-06-15 | 2022-06-17 | 96,154 | — | $0 | 143,672 | SEC↗ |
| PROG PROGENITY, INC. | A Award deriv | 2021-06-14 | 2021-06-16 | 51,724 | — | $0 | 51,724 | SEC↗ |
| PROG PROGENITY, INC. | A Award | 2021-06-14 | 2021-06-16 | 29,183 | — | $0 | 47,518 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2019-01-28 | 2019-01-29 | 2,000 | — | $0 | 79,427 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2019-01-28 | 2019-01-29 | 4,000 | — | $0 | 81,427 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2019-01-28 | 2019-01-29 | 4,000 | $9.88 | $39.5K | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2019-01-28 | 2019-01-29 | 2,000 | $3.22 | $6.4K | 2,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2019-01-28 | 2019-01-29 | 4,000 | $3.22 | $12.9K | 4,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2019-01-28 | 2019-01-29 | 2,000 | $9.91 | $19.8K | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2019-01-25 | 2019-01-29 | 6,000 | — | $0 | 85,427 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2019-01-25 | 2019-01-29 | 6,000 | $3.22 | $19.3K | 6,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2019-01-25 | 2019-01-29 | 6,000 | $9.60 | $57.6K | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2019-01-18 | 2019-01-23 | 2,000 | — | $0 | 91,427 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2019-01-18 | 2019-01-23 | 2,000 | $3.22 | $6.4K | 2,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2019-01-18 | 2019-01-23 | 2,000 | $9.40 | $18.8K | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2019-01-16 | 2019-01-18 | 3,046 | — | $0 | 93,427 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2019-01-16 | 2019-01-18 | 3,046 | $3.22 | $9.8K | 3,046 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2019-01-16 | 2019-01-18 | 3,046 | $9.27 | $28.2K | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2019-01-14 | 2019-01-16 | 954 | — | $0 | 96,473 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2019-01-14 | 2019-01-16 | 954 | $3.22 | $3.1K | 954 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2019-01-14 | 2019-01-16 | 954 | $9.20 | $8.8K | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2018-12-20 | 2018-12-21 | 190,000 | — | $0 | 190,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2018-12-10 | 2018-12-12 | 2,000 | — | $0 | 97,427 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2018-12-10 | 2018-12-12 | 2,000 | — | $0 | 99,427 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2018-12-10 | 2018-12-12 | 2,000 | $3.22 | $6.4K | 2,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2018-12-10 | 2018-12-12 | 2,000 | $3.22 | $6.4K | 2,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2018-12-10 | 2018-12-12 | 2,000 | $9.01 | $18.0K | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2018-12-10 | 2018-12-12 | 2,000 | $9.11 | $18.2K | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2018-11-21 | 2018-11-26 | 12,000 | — | $0 | 101,427 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2018-11-21 | 2018-11-26 | 2,455 | $9.01 | $22.1K | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2018-11-21 | 2018-11-26 | 12,000 | $9.06 | $108.7K | 2,455 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2018-11-21 | 2018-11-26 | 12,000 | $3.22 | $38.6K | 14,455 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2018-11-20 | 2018-11-21 | 9,127 | — | $0 | 113,427 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2018-11-20 | 2018-11-21 | 9,127 | $3.22 | $29.4K | 17,732 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2018-11-20 | 2018-11-21 | 9,127 | $8.52 | $77.8K | 8,605 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2018-11-20 | 2018-11-21 | 6,150 | $8.61 | $53.0K | 2,455 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2018-11-19 | 2018-11-21 | 193 | — | $0 | 122,554 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2018-11-19 | 2018-11-21 | 193 | $8.30 | $1.6K | 8,605 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2018-11-19 | 2018-11-21 | 193 | $3.22 | $621 | 8,798 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2018-11-08 | 2018-11-09 | 5,280 | — | $0 | 122,747 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2018-11-08 | 2018-11-09 | 5,280 | $3.22 | $17.0K | 13,885 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2018-11-08 | 2018-11-09 | 5,280 | $8.15 | $43.0K | 8,605 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2018-11-07 | 2018-11-09 | 300 | — | $0 | 128,027 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2018-11-07 | 2018-11-09 | 300 | $3.22 | $966 | 8,905 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2018-11-07 | 2018-11-09 | 300 | $8.00 | $2.4K | 8,605 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2018-11-05 | 2018-11-07 | 100 | — | $0 | 128,327 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2018-11-05 | 2018-11-07 | 100 | $3.22 | $322 | 8,705 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2018-11-05 | 2018-11-07 | 100 | $8.00 | $800 | 8,605 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2018-11-02 | 2018-11-06 | 1,000 | — | $0 | 128,427 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2018-11-02 | 2018-11-06 | 1,000 | $3.22 | $3.2K | 9,605 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2018-11-02 | 2018-11-06 | 1,000 | $8.00 | $8.0K | 8,605 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2018-11-01 | 2018-11-05 | 1,544 | $7.51 | $11.6K | 8,605 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2018-10-19 | 2018-10-23 | 100 | $7.50 | $750 | 10,149 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2017-12-20 | 2017-12-22 | 80,000 | — | $0 | 80,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2017-08-31 | 2017-09-05 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2017-02-27 | 2017-03-01 | 150,000 | — | $0 | 150,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2016-05-23 | 2016-05-25 | 129,427 | — | $0 | 129,427 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2016-01-26 | 2016-01-27 | 3,850 | $7.29 | $28.1K | 8,605 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2015-12-29 | 2015-12-31 | 62,573 | — | $0 | 62,573 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2015-01-26 | 2015-01-28 | 190,000 | — | $0 | 190,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2015-01-26 | 2015-01-28 | 10,000 | — | $0 | 10,000 | SEC↗ |